BNTC logo

Benitec Biopharma (BNTC) Cash From Investing

Annual CFI

-$179.00 K
-$178.00 K-17800.00%

June 30, 2024

Summary

Performance

1-Year Change

-17800%

3-Year Change

+19%

5-Year Change

+55.25%

15-Year Change

+22.88%

BNTC Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

55.09%
BNTC annual cash flow from investing activities is higher than 55.09% of companies in Healthcare sector

High & Low

All-time High

-$1000.00

3-Year Low

-$221.00 K

Earnings dates

Last Annual Earnings Report Date

Jun 30, 2024
BNTC previous annual earnings announcement was published on Jun 30, 2024

Next Annual Earnings Report Date

N/A
BNTC next annual earnings announcement has not yet been scheduled

OtherBNTCcash flowmetrics:

Annual CFF

$68.03 M
BNTC annual cash flow from financing activities is $68.03 million

Annual CFO

-$19.40 M
BNTC annual cash flow from operations is -$19.40 million

Annual FCF

-$19.58 M
BNTC annual free cash flow is -$19.58 million

Annual CAPEX

-
BNTC annual capital expenditures value is unknown

Quarterly CFI

-$12.00 K
-$12.00 K-100.00%

December 31, 2024

Summary

Performance

3-Month Change

-100%

1-Year Change

-100%

3-Year Change

-100%

5-Year Change

-100%

BNTC Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

50.83%
BNTC quarterly cash flow from investing activities is higher than 50.83% of companies in Healthcare sector

High & Low

All-time High

$1.35 M
BNTC quarterly cash flow from investing activities is currently -100.89% below its historical high of $1.35 million

3-Year Low

-$179.00 K

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
BNTC previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 13, 2025
BNTC next earnings announcement is scheduled for May 13, 2025

OtherBNTCcash flowmetrics:

Quarterly CFF

$17.87 M
BNTC quarterly cash flow from financing activities is $17.87 million

Quarterly CFO

-$7.70 M
BNTC quarterly cash flow from operations is -$7.70 million

Quarterly FCF

-$7.71 M
BNTC quarterly free cash flow is -$7.71 million

Quarterly CAPEX

-
BNTC quarterly capital expenditures value is unknown

TTM CFI

-$191.00 K
-$12.00 K-6.70%

December 31, 2024

Summary

Performance

3-Month Change

-6.7%

1-Year Change

-6.7%

3-Year Change

-6.7%

5-Year Change

-6.7%

BNTC TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

53.87%
BNTC TTM cash flow from investing activities is higher than 53.87% of companies in Healthcare sector

High & Low

All-time High

$1.06 M
BNTC TTM cash flow from investing activities is currently -118.03% below its historical high of $1.06 million

3-Year Low

-$191.00 K
BNTC TTM cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
BNTC previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 13, 2025
BNTC next earnings announcement is scheduled for May 13, 2025

OtherBNTCcash flowmetrics:

TTM CFF

$79.60 M
BNTC TTM cash flow from financing activities is $79.60 million

TTM CFO

-$21.75 M
BNTC TTM cash flow from operations is -$21.75 million

TTM FCF

-$21.94 M
BNTC TTM free cash flow is -$21.94 million

TTM CAPEX

-
BNTC TTM capital expenditures value is unknown

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

BNTC Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-10000.0%-100.0%-6.7%
3 y3 years+19.0%-100.0%-6.7%
5 y5 years+55.3%-100.0%-6.7%

BNTC Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year<-9999.0%+19.0%<-9999.0%+93.3%-251.6%at low
5 y5-year<-9999.0%+55.3%-108.5%+93.3%-251.6%+49.1%
alltimeall time<-9999.0%+62.4%-100.9%+99.2%-118.0%+87.3%

Benitec Biopharma Cash From Investing History

DateAnnualQuarterlyTTM
Dec 2024
-
-$12.00 K(<-9900.0%)
-$191.00 K(+6.7%)
Sep 2024
-
$0.00(0.0%)
-$179.00 K(0.0%)
Jun 2024
-$179.00 K(>+9900.0%)
$0.00(-100.0%)
-$179.00 K(-0.6%)
Mar 2024
-
-$179.00 K(<-9900.0%)
-$180.00 K(>+9900.0%)
Dec 2023
-
$0.00(0.0%)
-$1000.00(0.0%)
Sep 2023
-
$0.00(-100.0%)
-$1000.00(0.0%)
Jun 2023
-$1000.00(-92.3%)
-$1000.00(<-9900.0%)
-$1000.00(-92.3%)
Mar 2023
-
$0.00(0.0%)
-$13.00 K(0.0%)
Dec 2022
-
$0.00(0.0%)
-$13.00 K(0.0%)
Sep 2022
-
$0.00(-100.0%)
-$13.00 K(0.0%)
Jun 2022
-$13.00 K(-94.1%)
-$13.00 K(<-9900.0%)
-$13.00 K(-110.3%)
Dec 2021
-
$0.00(0.0%)
$126.00 K(-362.5%)
Sep 2021
-
$0.00(-100.0%)
-$48.00 K(-78.3%)
Jun 2021
-$221.00 K(+135.1%)
$141.00 K(-1040.0%)
-$221.00 K(-41.1%)
Mar 2021
-
-$15.00 K(-91.4%)
-$375.00 K(+4.2%)
Dec 2020
-
-$174.00 K(+0.6%)
-$360.00 K(+34.3%)
Sep 2020
-
-$173.00 K(+1230.8%)
-$268.00 K(+185.1%)
Jun 2020
-$94.00 K
-$13.00 K(<-9900.0%)
-$94.00 K(-50.2%)
Mar 2020
-
$0.00(-100.0%)
-$188.60 K(0.0%)
DateAnnualQuarterlyTTM
Dec 2019
-
-$82.00 K(-8300.0%)
-$188.60 K(+71.1%)
Sep 2019
-
$1000.00(-100.9%)
-$110.20 K(-0.9%)
Jun 2019
-$400.00 K(+270.4%)
-$107.60 K(+2888.9%)
-$111.20 K(-457.6%)
Dec 2018
-
-$3600.00(-111.7%)
$31.10 K(-128.8%)
Jun 2018
-$108.00 K(-53.5%)
$30.90 K(+713.2%)
-$108.10 K(-31.4%)
Mar 2018
-
$3800.00(-103.4%)
-$157.60 K(-13.3%)
Dec 2017
-
-$111.40 K(+254.8%)
-$181.80 K(-17.6%)
Sep 2017
-
-$31.40 K(+68.8%)
-$220.70 K(-4.9%)
Jun 2017
-$232.10 K(-9.1%)
-$18.60 K(-8.8%)
-$232.00 K(-25.4%)
Mar 2017
-
-$20.40 K(-86.4%)
-$311.00 K(-129.4%)
Dec 2016
-
-$150.30 K(+252.0%)
$1.06 M(-510.3%)
Sep 2016
-
-$42.70 K(-56.3%)
-$258.20 K(+1.1%)
Jun 2016
-$255.40 K(-34.1%)
-$97.60 K(-107.2%)
-$255.40 K(+61.9%)
Mar 2016
-
$1.35 M(-192.0%)
-$157.80 K(-89.5%)
Dec 2015
-
-$1.47 M(+3579.2%)
-$1.51 M(+3679.2%)
Sep 2015
-
-$39.90 K
-$39.90 K
Jun 2015
-$387.30 K(-18.5%)
-
-
Jun 2014
-$475.50 K(+1528.4%)
-
-
Jun 2013
-$29.20 K
-
-

FAQ

  • What is Benitec Biopharma annual cash flow from investing activities?
  • What is the all time high annual CFI for Benitec Biopharma?
  • What is Benitec Biopharma annual CFI year-on-year change?
  • What is Benitec Biopharma quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Benitec Biopharma?
  • What is Benitec Biopharma quarterly CFI year-on-year change?
  • What is Benitec Biopharma TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Benitec Biopharma?
  • What is Benitec Biopharma TTM CFI year-on-year change?

What is Benitec Biopharma annual cash flow from investing activities?

The current annual CFI of BNTC is -$179.00 K

What is the all time high annual CFI for Benitec Biopharma?

Benitec Biopharma all-time high annual cash flow from investing activities is -$1000.00

What is Benitec Biopharma annual CFI year-on-year change?

Over the past year, BNTC annual cash flow from investing activities has changed by -$178.00 K (-17800.00%)

What is Benitec Biopharma quarterly cash flow from investing activities?

The current quarterly CFI of BNTC is -$12.00 K

What is the all time high quarterly CFI for Benitec Biopharma?

Benitec Biopharma all-time high quarterly cash flow from investing activities is $1.35 M

What is Benitec Biopharma quarterly CFI year-on-year change?

Over the past year, BNTC quarterly cash flow from investing activities has changed by -$12.00 K (-100.00%)

What is Benitec Biopharma TTM cash flow from investing activities?

The current TTM CFI of BNTC is -$191.00 K

What is the all time high TTM CFI for Benitec Biopharma?

Benitec Biopharma all-time high TTM cash flow from investing activities is $1.06 M

What is Benitec Biopharma TTM CFI year-on-year change?

Over the past year, BNTC TTM cash flow from investing activities has changed by -$12.00 K (-6.70%)